FIELD: chemistry.
SUBSTANCE: invention relates to a method for 7,7,9-trimethyl-6,7-dihydro-furo[3,2-ƒ]quinoline synthesis, comprising the 5-aminobenzofuran condensation with acetone in the presence of n-toluenesulphonic acid and magnesium perchlorate at a temperature of 70-125°C in an autoclave. At that, 5-aminobenzofuran is obtained by a sequence of steps consisting of: a - n-anisidine acylation with acetic anhydride to give N-(4-methoxyphenyl)acetamide; b - N-(4-methoxyphenyl)acetamide obtained in step interaction with chloroacetyl chloride to give N-[3-(chloroacetyl)-4-hydroxyphenyl]acetamide; c - dihydrofurane cycle circuit closure by treating the product obtained in step b by sodium acetate and subsequent intermediate reduction without isolation from the reaction mixture by sodium borohydride to yield N-(3-hydroxy-2,3-dihydro-1-benzofuran-5-yl)acetamide; d - dehydration of the product obtained in step c by treatment with n-toluenesulphonic acid and magnesium perchlorate to yield N-1-benzofuran-5-yl acetamide; e - acidic hydrolysis of the product obtained in step d to yield 5-aminobenzofurane. The method may be used as the basis for synthesis of various derivatives of furodihydroquinolines (FDHQ) trimethyl substituted by quinoline ring, that are of practical interest as potential sensitizers for application in PUVA-treatment of skin diseases, and they may be used in various fields of technology as antioxidants and antiozonants .
EFFECT: simplification and cheapening of the desired product obtaining process and increase of its total output compared with the prototype.
2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF N-(6,8,8-TRIMETHYL-8,9-DIHYDROFURO[3,2-H]QUINOLIN-5-YL)ACETAMIDE AS AN AGENT FOR PHOTOTHERAPY OF PSORIASIS AND PSORIATIC ARTHRITIS | 2018 |
|
RU2686692C1 |
| 1',2',3'-TRIMETOXIBENZO[5',6:5,4]-1H-6,7-DIHYDROCYCLOGEPTA[3,2-f]BENZOFURAN DERIVATIVE AND ITS APPLICATION | 2015 |
|
RU2593998C1 |
| DERIVANT OF ACETAMID N-(1S)-1',2',3'-TRIMETHOXY-6,7-DIHYDRO-1H-BENZO[5',6':5,4]CYCLOHEPTA-[3,2-F]BENZOFURAN-1-IL) AND ITS APPLICATION | 2013 |
|
RU2538982C1 |
| DERIVATIVES OF NEURAMINIC ACID, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT AND PROPHYLAXIS OF INFLUENZA | 1997 |
|
RU2169145C2 |
| DI(3-SULPHOPHENYLPHOSPHINYL) DERIVATIVES OF 2,2'-BIPYRIDYL, 1,10-PHENANTHROLINE AND PYRIDINE DERIVATIVES AND SYNTHESIS METHOD THEREOF | 2015 |
|
RU2620265C1 |
| ISOQUINOLINONE DERIVATIVES USEFUL IN TREATING CANCER | 2015 |
|
RU2690853C2 |
| NOVEL PIRIDAZONES AND TRIAZINONES FOR TREATMENT AND PREVENTING OF HEPATITIS B VIRUS INFECTION | 2015 |
|
RU2664329C1 |
| CYCLIC CYANOENONE DERIVATIVES AS KEAP1 MODULATORS | 2021 |
|
RU2822828C1 |
| METHOD OF OBTAINING (±)-(12R*,13AR*,13BS*)-2,3,5,6,12,13,13A,13B- OCTAHYDRO-1H-INDOLO[3,2,1-DE]PYRIDO[3,2,1-IJ]NAPHTHYRIDINE-12-OL | 2023 |
|
RU2815974C1 |
| METHOD OF PRODUCING DEXMEDETOMIDINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2023 |
|
RU2824994C1 |
